Poolbeg CEO On The Biotech’s Big Bet On Small Molecules

In the latest episode of the In Vivo Podcast, Jeremy Skillington, CEO of Poolbeg Pharma, discussed the company’s ambitious pipeline and strategic direction.

Episode metadata supplied by the publisher feed · Published Aug 4, 2025

Embed this episode

Attribution link and audio player

NOW PLAYING

Poolbeg CEO On The Biotech’s Big Bet On Small Molecules

0:00 35:40

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Citeline Podcasts?

This episode is 35 minutes long.

When was this Citeline Podcasts episode published?

This episode was published on August 4, 2025.

Can I download this Citeline Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!